Comprehensively Analyze the Prognosis Significance and Immune Implication of PTPRO in Lung Adenocarcinoma

Figure 3

The value of PTPRO expression level in evaluating the prognosis of LUAD. (a, b) Univariate and multivariate regression analyses of PTPRO expression levels and clinical parameters. (c) Construction of nomogram by the PTPRO expression level and clinical characteristics for predicting the probability of 1-, 3-, and 5-year OS of LUAD patients.

(a)

(b)

(c)